ROOTPATH GENOMICS
RootPath is a Cambridge-based biotechnology company developing a powerful personalized T cell therapy platform that bridges precision medicine and cancer immunotherapy. Their next generation technologies allow us to precisely monitor, modulate and steer the immune system for a revolution in the diagnosis and treatment of cancer.
ROOTPATH GENOMICS
Industry:
Biotechnology
Founded:
2017-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.rootpath.com
Total Employee:
1+
Status:
Active
Total Funding:
68 M USD
Technology used in webpage:
Viewport Meta SSL By Default Google Font API LetsEncrypt Content Delivery Network Euro Organization Schema Google Apps For Business AJAX Libraries API Typekit
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Armonica
Armonica is an medtech focused on developing its proprietary long-read DNA sequencing technology for precision medicine applications.
Gelesis
Gelesis is a biotechnology company developing first-in-class therapeutics to safely treat obese, overweight, and diabetic patients.
NAVAN Technologies
NAVAN Technologies is a privately-held biotechnology company enabling the development of next generation cell and gene therapies
Stem Cell & Device Laboratory
Stem Cell & Device Laboratory is aiming to contribute to a healthy society with new cell application products.
StemoniX
StemoniX is a biotechnology company that focuses on stem cell technologies to meet the demands of drug discovery and personalized medicine.
Verigraft AB
Verigraft AB is a biotech company that generates personalized tissue-engineered transplants for use in regenerative medicine.
Current Employees Featured
Xi Chen Co-founder and Chief Executive Officer @ RootPath Genomics
Co-founder and Chief Executive Officer
2017-05-01
Yinquing Li Co-founder & Scientific Advisor @ RootPath Genomics
Co-founder & Scientific Advisor
Le Cong Co-Founder & Scientific Advisor @ RootPath Genomics
Co-Founder & Scientific Advisor
Cheryl Cui Co-founder @ RootPath Genomics
Co-founder
Ely Porter Co-Founder @ RootPath Genomics
Co-Founder
2017-05-01
Founder
Investors List
Sky9 Capital
Sky9 Capital investment in Series B - RootPath Genomics
Matrix Partners China
Matrix Partners China investment in Series B - RootPath Genomics
CDH Investments
CDH Investments investment in Series B - RootPath Genomics
Hony Capital
Hony Capital investment in Series B - RootPath Genomics
Baidu Ventures
Baidu Ventures investment in Series A - RootPath Genomics
Volcanics Venture
Volcanics Venture investment in Series A - RootPath Genomics
Sequoia Capital China
Sequoia Capital China investment in Series A - RootPath Genomics
Matrix Partners China
Matrix Partners China investment in Series A - RootPath Genomics
Nest.Bio Ventures
Nest.Bio Ventures investment in Series A - RootPath Genomics
Oriza Seed Capital (Oriza Yuandian)
Oriza Seed Capital (Oriza Yuandian) investment in Series A - RootPath Genomics
Official Site Inspections
http://www.rootpath.com
- Host name: 104.19.241.93
- IP address: 104.19.241.93
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "RootPath Genomics"
RootPath - Org Chart, Teams, Culture & Jobs - The Org
RootPath, Inc. is a Cambridge, MA-based early-stage biotechnology company focusing on next-generation immuno- and cell therapy. It takes less than ten minutes to set up your company …See details»
RootPath Genomics - Crunchbase Company Profile
RootPath Genomics is a biotechnology company developing a powerful personalized T cell therapy platform that bridges precision medicine. View contacts for RootPath Genomics to access new leads and connect with …See details»
Rootpath
RootPath is a synthetic biology company. We elevate the throughput of gene function interrogation by orders of magnitude. Our molecular programming-based DNA fragment assembly technology gives researchers and drug developers …See details»
RootPath Company Profile 2024: Valuation, Funding
RootPath is headquartered in Watertown, MA. What is the size of RootPath? RootPath has 13 total employees. What industry is RootPath in? RootPath’s primary industry is Drug Discovery. Is RootPath a private or public company? …See details»
RootPath - VentureRadar
Website: https://www.rootpath.com/ Develops molecular programming-based DNA assembly technology to enhance gene function interrogation, enabling personalized T cell therapies for …See details»
RootPath Genomics Company Profile - Office Locations ... - Craft
RootPath Genomics is a synthetic gene biotechnology company. It develops a personalized T-cell therapy platform that bridges precision medicine and cancer immunotherapy. The company is …See details»
RootPath - LinkedIn
RootPath | 838 followers on LinkedIn. Enabling biology at scale | RootPath is a synthetic biology company that elevates the throughput of gene function interrogation by orders of magnitude.See details»
RootPath Genomics - Contacts, Employees, Board Members
RootPath Genomics has 5 current employee profiles, including Co-founder and Chief Executive Officer Xi Chen. RootPath Genomics is a biotechnology company developing a powerful …See details»
RootPath - Overview, News & Similar companies | ZoomInfo.com
Who is RootPath. RootPath is a preclinical-stage biotechnology company pioneering personalized immunotherapy and cell therapy for solid tumors using its proprietary Synthetic Immunology …See details»
RootPath Raises $11 Million Series A to Accelerate Clinical …
Jan 6, 2020 · RootPath is a preclinical-stage biotechnology company pioneering personalized immunotherapy and cell therapy for solid tumors using its proprietary Synthetic Immunology …See details»
Root Path - Biotech Careers
RootPath is a Cambridge-based biotechnology company developing a personalized T cell therapy platform that bridges precision medicine and cancer immunotherapy. Business Areas: …See details»
RootPath Launches, Elevating Throughput of Gene Function …
Mar 21, 2022 · RootPath is advancing a diverse pipeline of T cell therapies while developing a potentially world-leading synthetic biology platform that will enable researchers, bioengineers …See details»
TCR Gene Synthesis and Screening at Scale — Rootpath
At RootPath, we redefine TCR discovery by dramatically increasing the throughput of TCR characterization, enabling exploration of a much wider sequence space. As highlighted in our …See details»
RootPath Announces Its Custom Gene Library, Slashing Gene …
Nov 21, 2023 · RootPath Custom Gene Library was created to meet the growing demand in affordable, high-throughput gene synthesis in fields such as basic life science research, drug …See details»
Vision2 — Rootpath
From pharmaceuticals to agriculture, synthetic biology is leading an industrial revolution that will reshape the world. As with previous industrial revolutions, new technologies are what drives …See details»
RootPath to Present at the Upcoming American Society of Gene
May 16, 2022 · Our Molecular Programming-based DNA fragment assembly technology gives researchers and drug developers unprecedented, equitable access to long synthetic genes …See details»
Discovery of tumor-reactive T cell receptors by massively parallel ...
Apr 23, 2024 · Here we describe a high-throughput, personalized TCR discovery pipeline that enables the assembly of complex synthetic TCR libraries in a one-pot reaction, followed by …See details»
Applications — Rootpath
The RootPath Gene Library is prepared using RootPath Biology's proprietary PathFinder DNA Assembly technology. Unlike traditional methods, the PathFinder DNA Assembly technology …See details»
Adultery is no longer illegal in New York : NPR
3 days ago · Adultery is no longer a crime in New York. Gov. Kathy Hochul on Friday signed off on repealing a 1907 law prohibiting the act. New York's penal law previously said that "a …See details»
Technologies — Rootpath
Instead, we molecularly program the assembly protocol into the sequences of the DNA strands so that tens of thousands of short DNA strands can self-assemble into thousands of long genes …See details»